Abstract
Faithful genome transmission requires the cooperation of a network of pathways including cell cycle checkpoint, DNA replication, repair and recombination. The different DNA repair pathways must also be coordinated as function of the type of damage, the cell cycle and differentiation. DNA double-strand breaks (DSBs) are highly toxic lesions, which can be produced by physiological cell processes, such as meiosis or V(D)J recombination or by genotoxic stresses, such as ionizing radiation or replication inhibition. In mammalian cells, two major classes of processes can repair DSBs: non-homologous end-joining (NHEJ) or homologous recombination (HR). It has been proposed that the two processes can compete, via the binding to the broken DNA ends by the Ku80-Ku70 heterodimer (NHEJ) versus RAD52 protein (HR). Consistent with the competition for the DNA ends model, mammalian NHEJ defective cells show increased HR, induced by DSB generating treatment; this stimulation is specific to DSB since neither spontaneous nor UV-C-induced HR are stimulated. However the regulation could be more complex since different cell situations can affect the choice between NHEJ and HR, such as the stage of embryonic development, the persistence and / or accumulation of DSBs. The phase of the cell cycle has also been proposed to affect this channeling. In addition, despite the cell cycle regulation, the two processes can cooperate or act sequentially. After describing the molecular mechanisms of NHEJ and HR processes, their regulation is presented and discussed in this review. A model of regulation of DSB repair with respect to the cell cycle is proposed.
Keywords: homologous recombination, non-homologous recombination, nhej, double-strand breaks, ionizing radiation, mammalian cells
Current Genomics
Title: Homologous Recombination, Non-Homologous End-Joining and Cell Cycle: Genomes Angels
Volume: 5 Issue: 1
Author(s): Delacote F., Guirouilh-Barbat J., Lambert S. and B. S. Lopez
Affiliation:
Keywords: homologous recombination, non-homologous recombination, nhej, double-strand breaks, ionizing radiation, mammalian cells
Abstract: Faithful genome transmission requires the cooperation of a network of pathways including cell cycle checkpoint, DNA replication, repair and recombination. The different DNA repair pathways must also be coordinated as function of the type of damage, the cell cycle and differentiation. DNA double-strand breaks (DSBs) are highly toxic lesions, which can be produced by physiological cell processes, such as meiosis or V(D)J recombination or by genotoxic stresses, such as ionizing radiation or replication inhibition. In mammalian cells, two major classes of processes can repair DSBs: non-homologous end-joining (NHEJ) or homologous recombination (HR). It has been proposed that the two processes can compete, via the binding to the broken DNA ends by the Ku80-Ku70 heterodimer (NHEJ) versus RAD52 protein (HR). Consistent with the competition for the DNA ends model, mammalian NHEJ defective cells show increased HR, induced by DSB generating treatment; this stimulation is specific to DSB since neither spontaneous nor UV-C-induced HR are stimulated. However the regulation could be more complex since different cell situations can affect the choice between NHEJ and HR, such as the stage of embryonic development, the persistence and / or accumulation of DSBs. The phase of the cell cycle has also been proposed to affect this channeling. In addition, despite the cell cycle regulation, the two processes can cooperate or act sequentially. After describing the molecular mechanisms of NHEJ and HR processes, their regulation is presented and discussed in this review. A model of regulation of DSB repair with respect to the cell cycle is proposed.
Export Options
About this article
Cite this article as:
F. Delacote, J. Guirouilh-Barbat, S. Lambert and Lopez S. B., Homologous Recombination, Non-Homologous End-Joining and Cell Cycle: Genomes Angels, Current Genomics 2004; 5 (1) . https://dx.doi.org/10.2174/1389202043490041
DOI https://dx.doi.org/10.2174/1389202043490041 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Protein Kinase C-θ (PKCθ), a Potential Drug Target for Therapeutic Intervention with Human T Cell Leukemias
Current Cancer Drug Targets Anatomical and Functional Relationships Between Sensory Nerves and Mast Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Autocrine and Paracrine Secretion of Vascular Endothelial Growth Factor in the Pre-Hypoxic Diabetic Retina
Current Diabetes Reviews Mechanisms of Inflammatory Atherosclerosis in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued) A Mysterious Case of Gastroparesis: Could the Secret be Found in a Drink?
Inflammation & Allergy - Drug Targets (Discontinued) Anti Inflammatory and Anti Arthritic Activity of Different Milk Based Formulation of Curcumin in Rat Model
Current Drug Delivery Cytokines and Invertebrates: TGF-β and PDGF
Current Pharmaceutical Design DNA Methylation in the Pathogenesis of Systemic Lupus Erythematosus
Current Pharmacogenomics Editorial [Autoinflammatory Disorders of Childhood: Continued Major Breakthroughs]
Current Rheumatology Reviews How Insulin Receptor Substrate Proteins Regulate the Metabolic Capacity of the Liver - Implications for Health and Disease
Current Medicinal Chemistry Kidney CYP450 Enzymes: Biological Actions Beyond Drug Metabolism
Current Drug Metabolism Study of Grumixama (Eugenia Brasiliensis, Lam) Fruit Pulp and Development of a Jelly: Rheological, Sensorial and Colorimetric Evaluation
The Natural Products Journal Recent Patents Relating to Tumor Suppressor Genes
Recent Patents on DNA & Gene Sequences Natural Product-Inspired Synthesis of Thiazolidine and Thiazolidinone Compounds and their Anticancer Activities
Current Pharmaceutical Design Assessment of Endothelial Function by Positron Emission Tomography
Current Cardiology Reviews Pharmaceutical and Biomedical Potential of PEGylated Dendrimers
Current Pharmaceutical Design Epitope Identification and Discovery Using Phage Display Libraries: Applications in Vaccine Development and Diagnostics
Current Drug Targets Sleep Apnea and Coronary Heart Disease: From Dusk Till Dawn and Further
Current Respiratory Medicine Reviews Phosphonic Esters and their Application of Protease Control
Current Pharmaceutical Design Hematopoietic Transplants for Disease Suppression and Cure in Type 1 Diabetes
Current Stem Cell Research & Therapy